Supplements

Guidelines supplements are written by experts and typically discuss a piece of national guidance, pulling out key learning points for GPs. Items may contain pharmaceutical promotional information.

Final version_Opioid supplement

Appropriate use of opioids for chronic pain in primary care

Commissioned by Grünenthal Ltd

This promotional supplement has been commissioned and funded by Grünenthal and developed in partnership with Guidelines. Information intended for healthcare professionals only.
View PALEXIA® SR tablets (tapentadol hydrochloride) prescribing and adverse event reporting information
M-PLX-UK-10-21-0036 October 2021

FINAL Acne supplement image

Managing acne well—a summary of the 2021 NICE guideline

Commissioned by Galderma UK Ltd

Information intended for UK healthcare professionals only. This promotional supplement has been commissioned and funded by Galderma and developed in partnership with Guidelines.
View Epiduo Gel 0.1% (0.1% adapalene & 2.5% benzoyl peroxide) prescribing information and adverse event reporting information.
View Epiduo Gel 0.3%/2.5 % (0.3% adapalene & 2.5% benzoyl peroxide) prescribing information and adverse event reporting information.
UKI-EDG-2100027
Date of preparation: October 2021

20210930_HRT prescribing supplement

Prescribing hormone replacement therapy (HRT) in postmenopausal women: a focus on Oestrogel® (estradiol) and Utrogestan® 100 mg (micronised progesterone)

Commissioned by Besins Healthcare (UK) Ltd

This prescribing supplement has been commissioned and funded by Besins Healthcare (UK) Ltd and developed in partnership with Guidelines. Includes promotional information.
View prescribing and adverse event reporting information
OES/2021/001a October 2021
For healthcare professionals only.

Emollient supplement_Index image

Recommending emollients for patients with atopic dermatitis or dry skin conditions

Commissioned by L’Oréal (UK) Limited

This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines
Date of preparation: January 2021

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.